The gap analysis and action plan

Hospital Pharmacy

Volumn 40, Issue 2, 2005, Pages 184-188

  Savage, Scott W ^a   Gomez, Tad A ^a   Burrell, Richard ^a  

^a NONE

Author keywords

Action Plan; Compounded sterile products (CSPs); Gap Analysis; JCAHO; USP Chapter 797

Indexed keywords

ACCREDITATION; ARTICLE; AWARENESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SERVICE; INJURY; MEDICAL LITERATURE; PRACTICE GUIDELINE;

EID: 13444282242     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870504000210     Document Type: Article

References (11)

1. Newton DW, Trissel LA. A primer on USP chapter 〈797〉, "pharmaceutical compounding-sterile preparations," and USP process for drug and practice standards. IJPC. 2004;8(4):251-263.
2. Kastango ES, Bradshaw BD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health Syst Pharm. 2004;61:1928-1938.
3. Kastango ES. The ASHP discussion guide on USP chapter 〈797〉: compounding sterile preparations. Available at: www.ashp.org. Accessed on August 22, 2004.
4. Morris AM, Schneider PJ, Pedersen CA et al. National survey of quality assurance for pharmacy-compounded sterile preparations. Am J Health Syst Pharm. 2003;60:2567-2576.
5. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: The United States pharmacopeia, 28th rev., and The National Formulary, 23rd ed. Rockville, MD: United States Pharmacopeial Convention; 2005:2461-2477.
6. Rich DS. USP/NF chapter 797: legal & JCAHO implications. Hosp Pharm. 2004;39(9):905-920.
7. American Society of Health-System Pharmacists, Kastango ES. 〈797〉 compliance advisor. Available at: www.797complianceadvisor.com. Accessed on January 4, 2005.
8. Hermann KG. Planning to meet the USP chapter 797 guidelines for compounding sterile preparations: an initial approach. Available at: www.jcrinc.com/printview.sp?durki=7844. Accessed on August 31, 2004.
9. Zhang J. Understanding pharmaceutical cleanroom design. ASHRAE Journal. 2004;9:29-33.
10. Kastango KS, DeMarco S. Pharmacy cleanroom project management considerations: an experience-based perspective. IJPC. 2001;5(3):221-225.
11. NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Available at: www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf. Accessed on January 3, 2005.